Literature DB >> 16673094

Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines.

Henrik S Thomsen1, Sameh K Morcos.   

Abstract

The interest in contrast-medium-induced nephropathy has increased considerably during the last few years. Various guidelines regarding identifying patients at risk and measures to reduce the incidence of this complication have been proposed. The aim of this review was to analyse whether there is some consistency amongst these guidelines. A Medline search for the keyword "contrast medium induced nephropathy" during the period from the beginning of 2003 through the end of September 2005 was carried out. Only papers in English were reviewed. Thirteen guidelines were identified. Inconsistency was observed regarding advise on the prophylactic use of drugs and the isoosmolar dimer to reduce the incidence of contrast-medium-induced nephropathy. Consistency was found in relation to the importance of hydration, cessation of intake of nephrotoxic drugs and administration of the lowest possible dose of contrast medium. No new consensus has been observed in comparison to the European Society for Urogenital Radiology (ESUR) guidelines, which were published in 1999.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673094     DOI: 10.1007/s00330-006-0223-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  29 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

Review 2.  Contrast-induced nephropathy.

Authors:  Tadhg G Gleeson; Sudi Bulugahapitiya
Journal:  AJR Am J Roentgenol       Date:  2004-12       Impact factor: 3.959

Review 3.  Contrast medium-induced nephropathy: critical review of the existing clinical evidence.

Authors:  Michael A Bettmann
Journal:  Nephrol Dial Transplant       Date:  2005-02       Impact factor: 5.992

Review 4.  Prevention of radiocontrast nephropathy.

Authors:  Julie Lin; Joseph V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-03       Impact factor: 2.894

Review 5.  Contrast-induced nephropathy.

Authors:  Peter A McCullough; Sandeep S Soman
Journal:  Crit Care Clin       Date:  2005-04       Impact factor: 3.598

6.  Effect of sodium bicarbonate preloading on ischemic renal failure.

Authors:  J L Atkins
Journal:  Nephron       Date:  1986       Impact factor: 2.847

7.  Are screening serum creatinine levels necessary prior to outpatient CT examinations?

Authors:  R B Tippins; W E Torres; B R Baumgartner; D A Baumgarten
Journal:  Radiology       Date:  2000-08       Impact factor: 11.105

Review 8.  Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

Authors:  S K Morcos; H S Thomsen; J A Webb
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 9.  Radiocontrast-induced acute renal failure.

Authors:  Steven D Weisbord; Paul M Palevsky
Journal:  J Intensive Care Med       Date:  2005 Mar-Apr       Impact factor: 3.510

10.  Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.

Authors:  Fernando Boccalandro; Muhammad Amhad; Richard W Smalling; Stefano Sdringola
Journal:  Catheter Cardiovasc Interv       Date:  2003-03       Impact factor: 2.692

View more
  10 in total

Review 1.  Recent hot topics in contrast media.

Authors:  Henrik S Thomsen
Journal:  Eur Radiol       Date:  2010-12-07       Impact factor: 5.315

Review 2.  Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma.

Authors:  Matthew K Tollefson; Naoki Takahashi; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

Review 3.  The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.

Authors:  Mei-Yi Wu; Hui-Fen Hsiang; Chung-Shun Wong; Min-Szu Yao; Yun-Wen Li; Chao-Ying Hsiang; Chyi-Huey Bai; Yung-Ho Hsu; Yuh-Feng Lin; Ka-Wai Tam
Journal:  Int Urol Nephrol       Date:  2013-01-03       Impact factor: 2.370

4.  No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.

Authors:  S Langner; S Stumpe; M Kirsch; M Petrik; N Hosten
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-04       Impact factor: 3.825

5.  Imaging patients with chronic kidney disease: CIN or NSF?

Authors:  H S Thomsen
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

6.  Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

Authors:  Sana Shoukat; Saqib A Gowani; Asif Jafferani; Sajid H Dhakam
Journal:  Cardiol Res Pract       Date:  2010-09-19       Impact factor: 1.866

7.  The value of blood oxygenation level-dependent (BOLD) MR imaging in differentiation of renal solid mass and grading of renal cell carcinoma (RCC): analysis based on the largest cross-sectional area versus the entire whole tumour.

Authors:  Guang-Yu Wu; Shi-Teng Suo; Qing Lu; Jin Zhang; Wan-Qiu Zhu; Jian-Rong Xu
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

8.  Comparison of the safety of seven iodinated contrast media.

Authors:  Jong-Mi Seong; Nam-Kyong Choi; Joongyub Lee; Yoosoo Chang; Ye-Jee Kim; Bo Ram Yang; Xue-Mei Jin; Ju-Young Kim; Byung-Joo Park
Journal:  J Korean Med Sci       Date:  2013-11-26       Impact factor: 2.153

Review 9.  Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.

Authors:  Liang Wang
Journal:  Hepat Med       Date:  2010-08-17

Review 10.  Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies.

Authors:  Umar Sadat
Journal:  ISRN Radiol       Date:  2013-09-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.